IP Library Granted Patent US 7,659,125
Granted Patent B2
US 7,659,125 · App. 10/550,324 · Granted Feb 9, 2010

Latex reagent for adiponectin analysis and method of adiponectin analysis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,659,125
App. No.
10/550,324
Granted
Feb 9, 2010
Kind
B2
Abstract

A latex reagent for analyzing adiponectin, comprising a suspension of latex particles carrying a substance which specifically binds to adiponectin, is disclosed. Further, a method for analyzing adiponectin, comprising (1) obtaining a biological liquid possibly containing adiponectin, and (2) bringing the biological liquid, while maintaining the state in which the biological liquid is obtained, into contact with a suspension of latex particles carrying a substance which specifically binds to adiponectin, and optically analyzing a degree of latex-particles-agglutination, is disclosed. According to the latex reagent and the method for analyzing adiponectin, a predilution or pretreatment of the biological liquid to be analyzed is not necessary. Further, the analysis can be performed rapidly and conveniently, and facilities therefor are not limited.

Claims (9)

1. A latex reagent for quantitatively measuring adiponectin, comprising a suspension of latex particles carrying an anti-adiponectin polyclonal antibody that binds to native adiponectin.

2. The latex reagent according to claim 1 , wherein the latex particles do not carry an anti-adiponectin monoclonal antibody.

3. A method for quantitatively measuring native adiponectin, comprising the steps of:

(1) obtaining a biological liquid possibly containing adiponectin, and

(2) bringing the biological liquid, without pretreatment of said liquid to obtain monomeric adiponectin or predilution, into contact with a suspension of latex particles carrying an anti-adiponectin polyclonal antibody that binds to native adiponectin, and optically analyzing a degree of latex-particles-agglutination, wherein said degree of latex-particle agglutination correlates to the level of adiponectin in said liquid.

4. The method according to claim 3 , wherein the latex particles do not carry an anti-adiponectin monoclonal antibody.

5. A method for quantitatively measuring the level of native adiponectin in a biological liquid, consisting of the steps of:

(1) obtaining a biological liquid possibly containing adiponectin; and

(2) bringing the biological liquid, without predilution or other pretreatment, into contact with a suspension of latex particles carrying an anti-adiponectin polyclonal antibody that binds to native adiponectin, and optically analyzing a degree of latex-particle-agglutination, wherein said degree of latex-particle agglutination correlates to the level of adiponectin in said liquid.

Assignments (3)
CHANGE OF NAME Recorded Feb 11, 2015
From: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 034947/0277 →
MERGER Recorded Nov 30, 2010
From: MITSUBISHI KAGAKU IATRON, INC.
To: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
Reel/Frame 025430/0962 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2005
From: TACHIKAWA, TETSUYA; AKAMATSU, SUGURU; SAWAI, TOKIO; NISHIMURA, AYAKO
To: MITSUBISHI KAGAKU IATRON, INC.; OTSUKA PAHARMACEUTICAL CO., LTD.
Reel/Frame 017790/0468 →